Medicrea Reports 1.2% Net Profit Loss in 2012 & Big US Plans in 2013

Spinal Tech

Medicrea reported a net profit loss of 1.2 percent in 2012. However, Medicrea, a company focused on orthopedic spine implants, reported an 8.5 percent sales increase in the United States. The company plans to develop sales activity in the U.S. with its PASS LP product and obtain FDA approval for its K-Jaws technology in 2013.

The group has also been in negotiation with potential American partners for its Granvia-C cervical disc.

More Articles on Spine Devices:

K2M Launches VENADO Biologic Bone Graft System

Amedica Valeo Interbody Fusion Device Hits 10k Implantations

X-spine Receives FDA Clearance for Silex Sacroiliac Joint Fusion Device

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers